Cognitive Screening in Lung Cancer Patients

Abroad (travel likely)Recruiting

Conditions

Lung Disease · NSCLC (Non-small Cell Lung Cancer) · SCLC

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Istituto Europeo di Oncologia, Milan, Italy
Contact: Study coordinator (Gabriella Pravettoni) · gabriella.pravettoni@ieo.it · +390257489731

Study leads

Gabriella Pravettoni
Principal Investigator
Istituto Europeo di Oncologia

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Pan-tumor MRD Study

Muscle Invasive Bladder Urothelial Carcinoma · Esophageal Cancer · Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

Abroad (travel likely)Recruiting

San Diego, United States · Maumee, United States

Biomarkers for Risk Stratification in Lung Cancer

Nodule Solitary Pulmonary · Non-small Cell Lung Cancer

Abroad (travel likely)Recruiting

San Francisco, United States · San Francisco, United States

ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs

NSCLC (Advanced Non-small Cell Lung Cancer) · EGFR Mutation Positive Advanced Non Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy

Lung Cancer (NSCLC)

Abroad (travel likely)Recruiting

Beijing, China